Wenzhou Kangning Hospital Dirección
Dirección controles de criterios 4/4
El CEO de Wenzhou Kangning Hospital es Lianyue Wang , nombrado en Sep 2011, tiene una permanencia de 13.17 años. compensación anual total es CN¥658.80K, compuesta por 71.1% salario y 28.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 4.74% de las acciones de la empresa, por valor de HK$43.38M. La antigüedad media del equipo directivo y de la junta directiva es de 2.8 años y 3.3 años, respectivamente.
Información clave
Lianyue Wang
Chief Executive Officer (CEO)
CN¥658.8k
Compensación total
| Porcentaje del salario del CEO | 71.1% |
| Permanencia del CEO | 13.2yrs |
| Participación del CEO | 4.7% |
| Permanencia media de la dirección | 2.8yrs |
| Promedio de permanencia en la Junta Directiva | 3.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Share Price Matching Investor Opinion
Sep 26
We Think The Compensation For Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) CEO Looks About Right
May 23Estimating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Feb 28Investors Continue Waiting On Sidelines For Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Jan 19Wenzhou Kangning Hospital (HKG:2120) Has A Somewhat Strained Balance Sheet
Nov 23Wenzhou Kangning Hospital (HKG:2120) Could Be Struggling To Allocate Capital
Jun 16Returns Are Gaining Momentum At Wenzhou Kangning Hospital (HKG:2120)
Mar 23Is Wenzhou Kangning Hospital (HKG:2120) Using Too Much Debt?
Dec 06Returns On Capital Are Showing Encouraging Signs At Wenzhou Kangning Hospital (HKG:2120)
Aug 11Calculating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Jul 09Wenzhou Kangning Hospital (HKG:2120) Is Experiencing Growth In Returns On Capital
May 12Wenzhou Kangning Hospital (HKG:2120) Has A Pretty Healthy Balance Sheet
Apr 10Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 25Will Wenzhou Kangning Hospital (HKG:2120) Multiply In Value Going Forward?
Jan 17
Should You Use Wenzhou Kangning Hospital's (HKG:2120) Statutory Earnings To Analyse It?
Dec 23If You Had Bought Wenzhou Kangning Hospital's (HKG:2120) Shares Five Years Ago You Would Be Down 42%
Dec 10Can Mixed Fundamentals Have A Negative Impact on Wenzhou Kangning Hospital Co., Ltd. (HKG:2120) Current Share Price Momentum?
Nov 27Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥93m |
| Mar 31 2024 | n/a | n/a | CN¥89m |
| Dec 31 2023 | CN¥659k | CN¥469k | CN¥86m |
| Sep 30 2023 | n/a | n/a | CN¥33m |
| Jun 30 2023 | n/a | n/a | -CN¥19m |
| Mar 31 2023 | n/a | n/a | -CN¥22m |
| Dec 31 2022 | CN¥683k | CN¥516k | -CN¥24m |
| Sep 30 2022 | n/a | n/a | CN¥12m |
| Jun 30 2022 | n/a | n/a | CN¥48m |
| Mar 31 2022 | n/a | n/a | CN¥46m |
| Dec 31 2021 | CN¥489k | CN¥397k | CN¥44m |
| Sep 30 2021 | n/a | n/a | CN¥45m |
| Jun 30 2021 | n/a | n/a | CN¥54m |
| Mar 31 2021 | n/a | n/a | CN¥55m |
| Dec 31 2020 | CN¥483k | CN¥326k | CN¥56m |
| Sep 30 2020 | n/a | n/a | CN¥49m |
| Jun 30 2020 | n/a | n/a | CN¥42m |
| Mar 31 2020 | n/a | n/a | CN¥49m |
| Dec 31 2019 | CN¥438k | CN¥325k | CN¥57m |
| Sep 30 2019 | n/a | n/a | CN¥74m |
| Jun 30 2019 | n/a | n/a | CN¥91m |
| Mar 31 2019 | n/a | n/a | CN¥86m |
| Dec 31 2018 | CN¥455k | CN¥324k | CN¥81m |
| Sep 30 2018 | n/a | n/a | CN¥73m |
| Jun 30 2018 | n/a | n/a | CN¥65m |
| Mar 31 2018 | n/a | n/a | CN¥57m |
| Dec 31 2017 | CN¥449k | CN¥324k | CN¥49m |
Compensación vs. Mercado: La compensación total de Lianyue($USD91.00K) está por debajo de la media de empresas de tamaño similar en el mercado Hong Kong ($USD232.99K).
Compensación vs. Ingresos: La compensación de Lianyue ha sido consistente con los resultados de la empresa en el último año.
CEO
Lianyue Wang (55 yo)
13.2yrs
Permanencia
CN¥658,800
Compensación
Ms. Lianyue Wang serves as General Manager at Wenzhou Kangning Hospital Co., Ltd. Since September 2011 and has been its Executive Director since April 2013 were she is primarily responsible for the overall...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 10.2yrs | CN¥580.73k | 25.64% HK$ 234.5m | |
| GM & Executive Director | 13.2yrs | CN¥658.80k | 4.74% HK$ 43.4m | |
| Vice GM | 10.3yrs | CN¥884.56k | 0.21% HK$ 1.9m | |
| Chief Financial Officer | 2.8yrs | sin datos | sin datos | |
| Chairman of Supervisory Committee | 2.4yrs | sin datos | sin datos | |
| Joint Company Secretary | 2.3yrs | sin datos | sin datos |
2.8yrs
Permanencia media
53yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 2120 se considera experimentado (2.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 10.2yrs | CN¥580.73k | 25.64% HK$ 234.5m | |
| GM & Executive Director | 11.6yrs | CN¥658.80k | 4.74% HK$ 43.4m | |
| Vice GM | 1.4yrs | CN¥884.56k | 0.21% HK$ 1.9m | |
| Chairman of Supervisory Committee | 2.8yrs | sin datos | sin datos | |
| Employee Representative Supervisor | 10.2yrs | CN¥38.00k | sin datos | |
| Non-Executive Director | 3.1yrs | sin datos | sin datos | |
| Independent Supervisor | 7.4yrs | sin datos | sin datos | |
| Shareholder Representative Supervisor | 3.1yrs | sin datos | sin datos | |
| Independent Non Executive Director | 4.4yrs | CN¥70.00k | sin datos | |
| Non-Executive Director | 3.4yrs | sin datos | sin datos | |
| Independent Non Executive Director | 1.4yrs | CN¥35.00k | sin datos | |
| Independent Non-Executive Director | 1.4yrs | CN¥35.00k | sin datos |
3.3yrs
Permanencia media
48.5yo
Promedio de edad
Junta con experiencia: La junta directiva de 2120 se considera experimentada (3.3 años de antigüedad promedio).